Bavarian Nordic secures second part of smallpox vaccine order from the US
The order, which was made public in April 2020, is worth USD 200m.
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN
Bavarian Nordic has secured the second part of a smallpox vaccine order from the US government, as Biomedical Advanced Research and Development Authority (BARDA) has exercised an option. Bavarian Nordic announces this on Wednesday evening.
In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.
The US retail chain has stopped selling its own private label hearing aids – and until the next generation comes along, other hearing companies selling products via Costco are enjoying the empty shelf space.